Identification of rat OX40 ligand by molecular cloning

被引:21
作者
Akiba, H
Atsuta, M
Yagita, H
Okumura, K
机构
[1] Juntendo Univ, Sch Med, Dept Immunol, Bunkyo Ku, Tokyo 1138421, Japan
[2] Japan Sci & Technol Corp, CREST, Chiyoda Ku, Tokyo 1010062, Japan
关键词
D O I
10.1006/bbrc.1998.9376
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
OX40 (CD134) is a member of the tumor necrosis factor (TNF) receptor superfamily first identified as a rat T cell activation marker. In the present study, we identified the rat Ligand for OX40 (OX40L) by molecular cloning. Rat OX40L cDNA was cloned from a HTLV-1-transformed rat T cell line by cross-hybridization with mouse OX40L cDNA. The predicted rat OX40L polypeptide is composed of 199 amino acids, showing 80.9 and 43.3% homology to mouse and human OX40L, respectively. Expression of rat OX40L mRNA was found in HTLV-1-transformed rat T cell lines. Expression of OX40L on the cell surface of these HTLV-1-transformed rat T cell lines was also demonstrated by flow cytometric analysis with a soluble fusion protein composed of the extracellular region of the Fc portion of human IgG (OX40-Ig). To explore the function of rat OX40L, we generated cDNA transfectants stably expressing rat OX40L. The rat OX40L transfectants exhibited a potent costimulatory activity for proliferation and IL-2 production of anti-CD3-stimulated rat T cells. These results indicated that rat OX40L can provide an efficient costimulation for rat T cells and that it may be involved in HTLV-1-associated pathologies in the rat system as has been suggested in the human system. (C) 1998 Academic Press.
引用
收藏
页码:131 / 136
页数:6
相关论文
共 33 条
[1]  
Barney-Knoerzer D., 1995, J CLIN INVEST, V96, P987
[2]   MOLECULAR CHARACTERIZATION OF MURINE AND HUMAN OX40/OX40 LIGAND SYSTEMS - IDENTIFICATION OF A HUMAN OX40 LIGAND AS THE HTLV-1-REGULATED PROTEIN GP34 [J].
BAUM, PR ;
GAYLE, RB ;
RAMSDELL, F ;
SRINIVASAN, S ;
SORENSEN, RA ;
WATSON, ML ;
SELDIN, MF ;
BAKER, E ;
SUTHERLAND, GR ;
CLIFFORD, KN ;
ALDERSON, MR ;
GOODWIN, RG ;
FANSLOW, WC .
EMBO JOURNAL, 1994, 13 (17) :3992-4001
[3]  
CALDERHEAD DM, 1993, J IMMUNOL, V151, P5261
[4]   COMPARISON OF CLINICAL AND EXPERIMENTAL UVEITIS [J].
FORRESTER, JV ;
LIVERSIDGE, J ;
DUA, HS ;
TOWLER, H ;
MCMENAMIN, PG .
CURRENT EYE RESEARCH, 1990, 9 :75-84
[5]   Immune regulation by CD40 and its ligand GP39 [J].
Foy, TM ;
Aruffo, A ;
Bajorath, J ;
Buhlmann, JE ;
Noelle, RJ .
ANNUAL REVIEW OF IMMUNOLOGY, 1996, 14 :591-617
[6]   IDENTIFICATION OF A HUMAN OX-40 LIGAND, A COSTIMULATOR OF CD4+ T-CELLS WITH HOMOLOGY TO TUMOR-NECROSIS-FACTOR [J].
GODFREY, WR ;
FAGNONI, FF ;
HARARA, MA ;
BUCK, D ;
ENGLEMAN, EG .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (02) :757-762
[7]   TUMOR-NECROSIS-FACTOR LIGAND SUPERFAMILY - INVOLVEMENT IN THE PATHOLOGY OF MALIGNANT-LYMPHOMAS [J].
GRUSS, HJ ;
DOWER, SK .
BLOOD, 1995, 85 (12) :3378-3404
[8]   Induction of OX40, a receptor of gp34, on T cells by trans-acting transcriptional activator, Tax, of human T-cell leukemia virus type I [J].
Higashimura, N ;
Takasawa, N ;
Tanaka, Y ;
Nakamura, M ;
Sugamura, K .
JAPANESE JOURNAL OF CANCER RESEARCH, 1996, 87 (03) :227-231
[9]  
HOLLSBERG P, 1993, NEW ENGL J MED, V328, P1173, DOI 10.1056/NEJM199304223281608
[10]   The human OX40/gp34 system directly mediates adhesion of activated T cells to vascular endothelial cells [J].
Imura, A ;
Hori, T ;
Imada, K ;
Ishikawa, T ;
Tanaka, Y ;
Maeda, M ;
Imamura, S ;
Uchiyama, T .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (05) :2185-2195